avatar
d*1
1
揣兜里差不多有一年了,一路往下疾走,速度快的我都不敢看,现在这是要往上爬的样
子么???
希望Carl Iahn争气,快快把它拉去10吧!!
avatar
w*m
2
能上2块就不错,这家就是被华尔街蹂躏烂的破鞋
avatar
j*x
3
拉回10得涨10倍啊。。。。。。 可能性太小了~~
除了那个aqxp,最近5年还有股票一口气涨十倍吗
avatar
m*h
4
大盘低位盘旋三周,长线选手终于出来了。
avatar
d*1
5
果然还是木有希望么,整个人都不好了。。。;)。。

【在 j******x 的大作中提到】
: 拉回10得涨10倍啊。。。。。。 可能性太小了~~
: 除了那个aqxp,最近5年还有股票一口气涨十倍吗

avatar
d*1
6
你看好它?除了tender offer的news和unusual volume,还为啥?

【在 m*********h 的大作中提到】
: 大盘低位盘旋三周,长线选手终于出来了。
avatar
l*m
7
http://www.thestreet.com/story/13277174/6/5-stocks-under-10-set
"One final under-$10 biopharmaceutical player that's starting to trend
within range of triggering a big breakout trade is Vivus (VVUS) , which
develops and commercializes therapies to address unmet needs in obesity,
sleep apnea, diabetes, and sexual health in the U.S. and the European Union.
This stock has been hit hard by the bears over the last three months, with
shares down large by 50.2%.
If you take a glance at the chart for Vivus, you'll notice that this stock
has been uptrending strong over the last few weeks, with shares moving
higher from its low of 94 cents to its intraday high on Wednesday of $1.24 a
share. During that uptrend, this stock has been making mostly higher lows
and higher highs, which is bullish technical price action. Shares of Vivus
ripped higher on Wednesday right off its 20-day moving average of $1.13 with
strong upside volume flows. That move is now quickly pushing this stock
within range of triggering a big breakout trade.
"
avatar
l*m
8

Union.
with
a

【在 l*********m 的大作中提到】
: http://www.thestreet.com/story/13277174/6/5-stocks-under-10-set
: "One final under-$10 biopharmaceutical player that's starting to trend
: within range of triggering a big breakout trade is Vivus (VVUS) , which
: develops and commercializes therapies to address unmet needs in obesity,
: sleep apnea, diabetes, and sexual health in the U.S. and the European Union.
: This stock has been hit hard by the bears over the last three months, with
: shares down large by 50.2%.
: If you take a glance at the chart for Vivus, you'll notice that this stock
: has been uptrending strong over the last few weeks, with shares moving
: higher from its low of 94 cents to its intraday high on Wednesday of $1.24 a

avatar
d*1
9
这个我也读了。。但是最大的concerns是它这个治obesity的药被几个大的phamacy
benefit plans excluded,替代viagra的新药貌似也没钱marketing好,所以你给的
chart才滑坡地那么吓人(°_°)

Union.
with
a

【在 l*********m 的大作中提到】
: http://www.thestreet.com/story/13277174/6/5-stocks-under-10-set
: "One final under-$10 biopharmaceutical player that's starting to trend
: within range of triggering a big breakout trade is Vivus (VVUS) , which
: develops and commercializes therapies to address unmet needs in obesity,
: sleep apnea, diabetes, and sexual health in the U.S. and the European Union.
: This stock has been hit hard by the bears over the last three months, with
: shares down large by 50.2%.
: If you take a glance at the chart for Vivus, you'll notice that this stock
: has been uptrending strong over the last few weeks, with shares moving
: higher from its low of 94 cents to its intraday high on Wednesday of $1.24 a

avatar
d*1
10
Carl Icahn到底看到了什么亮点?

【在 l*********m 的大作中提到】
:
: Union.
: with
: a

avatar
w*b
11
nflx,从12年到现在10倍

【在 j******x 的大作中提到】
: 拉回10得涨10倍啊。。。。。。 可能性太小了~~
: 除了那个aqxp,最近5年还有股票一口气涨十倍吗

avatar
d*1
12
那没看我以前胆大买的siri, 7分到3块

【在 w*b 的大作中提到】
: nflx,从12年到现在10倍
avatar
w*b
13
炒垃圾股是撞大运,跟炒5$以上的股票不一样

【在 d********1 的大作中提到】
: 那没看我以前胆大买的siri, 7分到3块
avatar
l*m
14
这个不重要,重要的是市场的反应。连VVUS的合同经销商QDII盘后都涨了不少。
明天若能收绿,我要加仓。现持2000股而已。
觉得老狐狸此举意味着2020之前公司不会倒。
听过CEO Seth的CC,没有什么生气的一个人,不过,踏实可信。

【在 d********1 的大作中提到】
: Carl Icahn到底看到了什么亮点?
avatar
d*1
15
做药的,踏实固然好,做药的ceo,光踏实不够啊,不会marketing,有几个FDA
approved的药在手,所以去年买它,但是revenue不见涨,经营战略有问题。。希望
board里能进几个厉害的。。明天我也看风向加点。。多谢点评!!

【在 l*********m 的大作中提到】
: 这个不重要,重要的是市场的反应。连VVUS的合同经销商QDII盘后都涨了不少。
: 明天若能收绿,我要加仓。现持2000股而已。
: 觉得老狐狸此举意味着2020之前公司不会倒。
: 听过CEO Seth的CC,没有什么生气的一个人,不过,踏实可信。

avatar
C*1
16
这VVUS看起来不错,短线看涨。
avatar
l*m
17
涨太多了,先出来了。

【在 C********1 的大作中提到】
: 这VVUS看起来不错,短线看涨。
avatar
d*1
18
Shorts are covering today ;)..

【在 l*********m 的大作中提到】
: 涨太多了,先出来了。
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。